Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer

ClinicalTrials.gov ID: NCT00020657

Public ClinicalTrials.gov record NCT00020657. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:36 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Treatment of Delayed Nausea: What Works Best?

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Antiemetic drugs may help to reduce or prevent nausea and vomiting in patients being treated with chemotherapy. PURPOSE: This randomized phase III trial is comparing how well different antiemetic drugs work in preventing delayed nausea after chemotherapy in patients who have cancer.

Study identification

NCT ID
NCT00020657
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gary Morrow
Other
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2001 (Type not available)
Primary completion
Oct 2004 (Actual)
Completion
Oct 2004 (Actual)
Last update posted
Oct 15, 2015

2001 – 2004

United States locations

U.S. sites
15
U.S. states
13
U.S. cities
15
Facility City State ZIP Site status
MBCCOP - Gulf Coast Mobile Alabama 36688 —
CCOP - Western Regional, Arizona Phoenix Arizona 85006-2726 —
CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale Arizona 85259-5404 —
CCOP - Colorado Cancer Research Program, Incorporated Denver Colorado 80224 —
MBCCOP - Hawaii Honolulu Hawaii 96813 —
CCOP - Central Illinois Decatur Illinois 62526 —
CCOP - Wichita Wichita Kansas 67214-3882 —
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731 —
CCOP - Northern New Jersey Hackensack New Jersey 07601 —
CCOP - North Shore University Hospital Manhasset New York 11030 —
CCOP - Southeast Cancer Control Consortium Winston-Salem North Carolina 27104-4241 —
CCOP - Columbus Columbus Ohio 43206 —
CCOP - Dayton Dayton Ohio 45429 —
CCOP - Greenville Greenville South Carolina 29615 —
CCOP - Northwest Tacoma Washington 98405-0986 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00020657, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 15, 2015 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00020657 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →